Search

Carl Stuart Miller

Examiner (ID: 16590)

Most Active Art Unit
3402
Art Unit(s)
3747, 3402, 2602, 3403
Total Applications
2728
Issued Applications
2458
Pending Applications
40
Abandoned Applications
230

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20458364 [patent_doc_number] => 20260007784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-08 [patent_title] => USE OF LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER [patent_app_type] => utility [patent_app_number] => 19/326445 [patent_app_country] => US [patent_app_date] => 2025-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5004 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19326445 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/326445
USE OF LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER Sep 10, 2025 Pending
Array ( [id] => 20422934 [patent_doc_number] => 20250385019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-18 [patent_title] => COPPER-64 COMPOSITIONS AND FORMULATIONS [patent_app_type] => utility [patent_app_number] => 19/242849 [patent_app_country] => US [patent_app_date] => 2025-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48996 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19242849 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/242849
COPPER-64 COMPOSITIONS AND FORMULATIONS Jun 17, 2025 Pending
Array ( [id] => 20196644 [patent_doc_number] => 20250273354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-28 [patent_title] => PURIFICATION PROCESS FOR THE PREPARATION OF NON-CARRIER ADDED COPPER-64 [patent_app_type] => utility [patent_app_number] => 19/195850 [patent_app_country] => US [patent_app_date] => 2025-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16901 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19195850 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/195850
PURIFICATION PROCESS FOR THE PREPARATION OF NON-CARRIER ADDED COPPER-64 Apr 30, 2025 Pending
Array ( [id] => 20153228 [patent_doc_number] => 20250253066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-07 [patent_title] => PURIFICATION PROCESS FOR THE PREPARATION OF NON-CARRIER ADDED COPPER-64 [patent_app_type] => utility [patent_app_number] => 19/184830 [patent_app_country] => US [patent_app_date] => 2025-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16884 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19184830 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/184830
Purification process for the preparation of non-carrier added copper-64 Apr 20, 2025 Issued
Array ( [id] => 20163924 [patent_doc_number] => 20250255970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-14 [patent_title] => BIOORTHOGONAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 19/180813 [patent_app_country] => US [patent_app_date] => 2025-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32609 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19180813 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/180813
BIOORTHOGONAL COMPOSITIONS Apr 15, 2025 Pending
19/030236 COPPER-64 COMPOSITIONS AND FORMULATIONS Jan 16, 2025 Pending
Array ( [id] => 19889173 [patent_doc_number] => 20250114485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-10 [patent_title] => GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING [patent_app_type] => utility [patent_app_number] => 18/983625 [patent_app_country] => US [patent_app_date] => 2024-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24828 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18983625 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/983625
Gadolinium chelate compounds for use in magnetic resonance imaging Dec 16, 2024 Issued
Array ( [id] => 20006011 [patent_doc_number] => 20250144233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-08 [patent_title] => NOVEL GENE DELIVERY AGENTS [patent_app_type] => utility [patent_app_number] => 18/932511 [patent_app_country] => US [patent_app_date] => 2024-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13926 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18932511 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/932511
Gene delivery agents Oct 29, 2024 Issued
Array ( [id] => 20048410 [patent_doc_number] => 20250186632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-12 [patent_title] => FIBROBLAST ACTIVATION PROTEIN TARGETING PEPTIDES [patent_app_type] => utility [patent_app_number] => 18/930419 [patent_app_country] => US [patent_app_date] => 2024-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7425 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18930419 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/930419
Fibroblast activation protein targeting peptides Oct 28, 2024 Issued
Array ( [id] => 19528142 [patent_doc_number] => 20240352044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => METAL ALKOXIDE COMPOUND, THIN FILM FORMING RAW MATERIAL, AND THIN FILM PRODUCTION METHOD [patent_app_type] => utility [patent_app_number] => 18/757905 [patent_app_country] => US [patent_app_date] => 2024-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10594 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 340 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18757905 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/757905
METAL ALKOXIDE COMPOUND, THIN FILM FORMING RAW MATERIAL, AND THIN FILM PRODUCTION METHOD Jun 27, 2024 Pending
Array ( [id] => 19912408 [patent_doc_number] => 12288627 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-04-29 [patent_title] => Copper-64 compositions and formulations [patent_app_type] => utility [patent_app_number] => 18/745906 [patent_app_country] => US [patent_app_date] => 2024-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 31291 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18745906 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/745906
Copper-64 compositions and formulations Jun 16, 2024 Issued
Array ( [id] => 19943513 [patent_doc_number] => 12315649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-05-27 [patent_title] => Purification process for the preparation of non-carrier added copper-64 [patent_app_type] => utility [patent_app_number] => 18/745896 [patent_app_country] => US [patent_app_date] => 2024-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16894 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18745896 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/745896
Purification process for the preparation of non-carrier added copper-64 Jun 16, 2024 Issued
Array ( [id] => 19483847 [patent_doc_number] => 20240331889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-03 [patent_title] => PURIFICATION PROCESS FOR THE PREPARATION OF NON-CARRIER ADDED COPPER-64 [patent_app_type] => utility [patent_app_number] => 18/733537 [patent_app_country] => US [patent_app_date] => 2024-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15281 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18733537 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/733537
PURIFICATION PROCESS FOR THE PREPARATION OF NON-CARRIER ADDED COPPER-64 Jun 3, 2024 Pending
Array ( [id] => 20592475 [patent_doc_number] => 12576171 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-17 [patent_title] => Composition of radioactive and non-radioactive microparticles [patent_app_type] => utility [patent_app_number] => 18/655741 [patent_app_country] => US [patent_app_date] => 2024-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4379 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18655741 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/655741
Composition of radioactive and non-radioactive microparticles May 5, 2024 Issued
Array ( [id] => 19799071 [patent_doc_number] => 20250064996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => STABILIZED COMPOSITIONS OF RADIONUCLIDES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/649569 [patent_app_country] => US [patent_app_date] => 2024-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61040 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18649569 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/649569
STABILIZED COMPOSITIONS OF RADIONUCLIDES AND USES THEREOF Apr 28, 2024 Pending
Array ( [id] => 19387576 [patent_doc_number] => 20240277446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => MULTI-MODE IMAGING MARKERS [patent_app_type] => utility [patent_app_number] => 18/646526 [patent_app_country] => US [patent_app_date] => 2024-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15431 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18646526 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/646526
Multi-mode imaging markers Apr 24, 2024 Issued
Array ( [id] => 19585074 [patent_doc_number] => 20240382631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-21 [patent_title] => USE OF LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER [patent_app_type] => utility [patent_app_number] => 18/628570 [patent_app_country] => US [patent_app_date] => 2024-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8878 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18628570 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/628570
USE OF LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER Apr 4, 2024 Pending
Array ( [id] => 19462557 [patent_doc_number] => 20240316226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => RADIOPHARMACEUTICAL CONJUGATE COMPOUND FOR DIAGNOSIS AND/OR THERAPEUTIC USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/614094 [patent_app_country] => US [patent_app_date] => 2024-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12061 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18614094 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/614094
Radiopharmaceutical conjugate compound for diagnosis and/or therapeutic uses thereof Mar 21, 2024 Issued
Array ( [id] => 19563571 [patent_doc_number] => 12138322 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-12 [patent_title] => Method of preventing the development of melanoma [patent_app_type] => utility [patent_app_number] => 18/610095 [patent_app_country] => US [patent_app_date] => 2024-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 8217 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18610095 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/610095
Method of preventing the development of melanoma Mar 18, 2024 Issued
Array ( [id] => 19403535 [patent_doc_number] => 20240287046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => COMPOUNDS AND RADIOLIGANDS FOR TARGETING NEUROTENSIN RECEPTOR AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/604397 [patent_app_country] => US [patent_app_date] => 2024-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27981 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18604397 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/604397
Compounds and radioligands for targeting neurotensin receptor and uses thereof Mar 12, 2024 Issued
Menu